Procter & Gamble Health Limited (PGHL) has announced a top-level management change. The company informed exchanges on Tuesday, September 16, 2025, that Mr. Lokesh Chandak, Director & Chief Financial Officer, has resigned effective September 30, 2025, to take up a new assignment at P&G as Senior Director – Finance & Accounting, Feminine Care – Asia Pacific Enterprise Markets, Middle East, and Africa.
The Board has approved the appointment of Mr. Shashank Srowthy as Chief Financial Officer and Additional (Executive) Director, effective October 1, 2025, subject to regulatory approvals. Mr. Srowthy, a Bachelor of Electronics & Telecommunication Engineering from Pune University and a Master of Management Studies from JBIMS, Mumbai, has over 14 years of experience across finance roles at P&G, spanning India, Dubai, and Singapore.
He will serve as Additional Director up to the ensuing Annual General Meeting, with his appointment as Executive Director subject to shareholder and Central Government approval. The company confirmed that Mr. Srowthy is not debarred from holding directorship by SEBI, MCA, or any other authority.
This leadership transition marks an important step for P&G Health, aligning with its long-term growth and governance framework.
